AKT1 and Insulin resistance: Cannabinoid can increase the phosphorylation of Akt at Thr34 by inhibiting the de novo synthesis of ceramide, increase the activity of Akt enzyme and inactivate GSK-3β enzyme, thereby improving hepatic insulin sensitivity and treating insulin resistance in obese animal models (Bzdęga et al., 2023).